Limited durability fastening for a garment

Abstract
A limited durability fastening for a garment. The garment is provided with fastening members which engage to close the fastening and the fastening members are provided with means for controlling the degradation of the closure strength of the fastening as it is opened and closed and thus the number of permissible closures of the fastening having a pre-determined closure strength. The garment is particularly useful when fitted to a foot where short life is desirable at low cost or to a garment where re-use is to be discouraged for either clinical or commercial reasons.
Description
FIELD OF THE INVENTION

The present invention relates to fastenings for garments and particularly to a short life fastening for a garment for use in the medical field.


BACKGROUND OF THE INVENTION

The use of an inflatable garment applied to a limb or other area of the human body as a means of enhancing blood circulation is a well established technique with proven clinical benefits.


The garment usually comprises an inflatable bladder contained as part of or integral to a means of attaching or securing the garment about the area to be treated. During use the bladder is filled with a fluid such as air to expand and apply force to the body, directed in such a way as to empty the veins of blood. The bladder is held pressurised for a period before releasing the fluid and then the cycle repeated. The rate of filling or venting of the bladder may vary from fractions of a second to several seconds according to the application.


The garment is attached for example to the foot normally by means of hook and loop closure over the dorsum of the foot and additionally around the heel.


SUMMARY

It is an object of the invention to provide means by which the garment can be advantageously fitted to the foot by using a closure means of limited durability as would be appropriate for example to a short life, low cost garment or to an item where re-use was to be discouraged for either clinical or commercial reasons.


The preferred embodiments of the invention disclosed herein have in mind primarily existing foot impulse technology devices such as the A-V Impulse System®. There will be applications for this limited durability closure technology beyond such use in both the medical and wider areas of application where closure of one or more components are required to be made reliably more than once, but not more than several times.


According to the invention there is provided a limited durability fastening for a garment comprising at least two garment elements to be fastened together with a predetermined closure strength, each garment element being provided with a fastening member which members engage to close the fastening, and means for controlling the degradation of the closure strength of the fastening as it is opened and closed and thus the number of permissible closures of the fastening having a predetermined closure strength.


According to another aspect of the invention there is provided a short life impulse therapy garment for the foot comprising a foot wrap and an ankle strap for retaining the foot wrap on the foot, said foot wrap incorporating an inflatable bladder for location in the plantar arch of the foot cyclically to pump the foot in accordance with a predetermined pressure and cycle time, first and second fastening members respectively for securing the ankle strap to the foot wrap to hold the foot wrap in place and the foot wrap around the foot with a predetermined closure strength sufficient to resist separation under impulse pressure, said first and second fastening members having two garment closure parts one of which is provided with an adhesive tab or adhesively treated area and the other part being formed of a material capable of degrading the adhesive of the tab or treated area upon contact therewith, and means applied to said material for controlling the degradation of the adhesive tab or adhesively treated area so as to determine the permissible number of make or break closures of said first and second fastening devices having said contact strength required to prevent said impulse pressure from opening the fastenings.


In accordance with a yet further aspect of the invention there is provided a method of providing a limited durability fastening for a garment comprising providing one fastening garment element of the garment with an adhesive tab and/or adhesively treated area, providing another fastening garment element of the garment with a contact zone or zones formed of a material capable of degrading the adhesive of the tab or treated area upon contact therewith, and modifying the garment material at said contact zone or zones to control the degradation of the adhesive tab or adhesively treated area when contact is made therebetween thereby to determine the permissible number of make and break closures of the fastening having a predetermined contact strength.





BRIEF DESCRIPTION OF THE DRAWINGS

Other features and advantages of the invention as broadly defined in the preceding paragraphs will become evident from a reading of the following description of preferred embodiments written with reference to the accompanying drawings wherein:



FIG. 1 is an isometric view showing a foot impulse technology garment mounted to the foot in accordance with the prior art;



FIG. 2 is an isometric view similar to FIG. 1 but where the garment is constructed in accordance with the present invention;



FIG. 3 is an isometric view showing a typical arrangement of an adhesive bond closure between the ends of a hoop of non-woven material in accordance with the invention;



FIG. 4 is a cross-sectional view of the fastening in accordance with one embodiment of the invention;



FIGS. 5a, 5b, 5c and 5d show cross-sectional views of various embodiments of the fastening in accordance with the invention;



FIGS. 6a and 6b show in cross-sectional view and plan view respectively a fastening in accordance with a further embodiment of the invention;



FIG. 6c is a graph depicting the relationship between closure strength and repeated fastenings of the embodiment of the invention as shown in FIGS. 6a and 6b;



FIGS. 7a and 7b show in cross-sectional view and plan view respectively a fastening in accordance with an alternative embodiment of the invention;



FIG. 8 is a graph depicting the relative strength of the closure fastening shown in FIG. 8 over a number of closure cycles;



FIG. 9 is a plan view showing a means of treating the surface of a normal non-woven material in a predetermined pattern to achieve the results of the invention in accordance with a preferred embodiment;



FIG. 10 is a plan view showing how the grid arrangement of FIG. 9 may be replaced by an irregular or even random disposition of surface modified zones in accordance with an embodiment of the invention;



FIG. 11 shows in isometric view a further embodiment of the invention wherein the surface modified zones and untreated non-woven zones may be arranged in a non-linear form;



FIGS. 12a and 12b illustrate in sectional view a further possibility of treating the surface of unwoven material to provide a variation of ablation capability;



FIGS. 13a and 13b shown in cross-sectional and exploded isometric view a means of obtaining a variable thickness bonding coat to form the surface treated zone in accordance with an embodiment of the invention;



FIG. 14 shows a sectional view of a means of applying a bonding coat to the surface of a non-woven material to provide the fastening device in accordance with the invention;



FIG. 15 is an isometric view illustrating a means of identifying degradation of the closure fastening in accordance with the invention;



FIGS. 16a and 16b show further means for identifying degradation of a closure fastening in accordance with the invention;



FIG. 17 shows in isometric view a further modification of the closure fastening in accordance with the invention to provide a combined dual closure system;



FIGS. 18a and 18b show the improved modification to the closure fastening in accordance with the invention provided by the modification illustrated in FIG. 17;



FIGS. 19a, 19b, 19c and 19d show respectively a plan view, a detail and two sectional views illustrating a complete closure system for a short life foot impulse technology garment incorporating the concepts of the present invention;



FIG. 20 illustrates a further variant in isometric view of a fastening for a garment in accordance with the present invention.





DETAILED DESCRIPTION

The existing foot mounted impulse therapy garment shown in FIG. 1 comprises of a wrap or upper 1 incorporating a heel strap 2, both configured anatomically to conform to the foot and be secured over the foot and around the ankle. The garment is secured to the foot at the dorsum by hook closure dorsum 3 engaging with loop material being the outside facing of the upper. Similarly, the garment is prevented from sliding forward on the foot by closure of the hook closure heel strap 4 with the outer facing of the upper.


Within the garment is a bladder located between the upper and foot that is rapidly inflated in a fraction of a second to ˜200 mmHg with a fluid such as air to apply force to the limb and held pressurised for up to 3 seconds before venting. The dorsum closure and heel strap closure must resist the impulsive inflation force repeatedly applied over the treatment period ranging from a few hours to several days without failure. In addition for an extended use garment the nurse or carer is required to remove the garment to inspect the condition of the patient's skin periodically before re-applying the garment. Over, for example, a 10 day period the garment may be removed and refitted 20 or 30 times and the integrity of the closure system must be maintained.


In an alternative garment intended for short application use the inclusion of a highly durable conventional hook and loop closure system need not be specified but nevertheless closure integrity must be maintained over the reduced time period and some accommodation be made to allow adjustment at the initial fit-up and singular or occasional inspection of the limb.



FIG. 2 is an isometric view showing an alternative short life Foot Impulse Technology garment and is essentially a similar device to FIG. 1 with the alteration that the upper 1 and/or heel strap 2 are fabricated from different materials than previously. The garment is secured around the foot at the dorsum by an adhesive closure dorsum 5 engaging with the outside facing of the upper. Similarly, the garment is prevented from sliding forward on the foot by closure of the adhesive closure heel strap 6 with the outer facing of the upper.


Whereas it is conventional to utilise a fabric foam laminate material for the upper, for a short life garment a non-woven material may be specified with adequate strength, compliance and durability for the application. In the revised construction it will be recognised that the traditional mechanical closure, by engagement of the hook fastener with the loop of the fabric, has been replaced by an adhesive bond between the adhesive tab and the surface of the non-woven material.



FIG. 3 is an isometric view showing a typical arrangement of an adhesive bond closure between, for example, the ends of a hoop of non-woven material 7 using an adhesive tab 8.


A characteristic of an adhesive bond closure made between an adhesive medium and a non-woven material is that fibres of the non-woven are transferred from the non-woven to the surface of the adhesive medium when the closure is separated. According to the degree of receptivity of the adhesive and entanglement of the non-woven the transfer can range from minimal to total but the exchange may cause a degradation of the adhesion (through clogging or masking) or failure of the non-woven (through thinning or tearing) or both. Such circumstances must be carefully modified if the objective is for the closure life to exceed a single make and break closure or to avoid multiple closures. Further explanation will reveal how this may be achieved through several alternative techniques to engineer a limited durability closure system having the characteristic of adequate closure strength, for example, over 2 to 5 make and break closure cycles.


To prevent, limit or control fibre transfer from the non-woven material to the adhesive medium a means of modifying the surface or avoiding direct contact with the shedding fibres is essential.



FIGS. 4 & 5
a-d are sectional views showing alternative methods.


In FIG. 4, two non-woven components 9, 10 are to be joined by an adhesive tab 8 acting on to a surface modified zone 11 bonded to the attachment side 10a of non-woven 10. The surface modification may take the form of U.V cured ink or adhesive coating or a filmic layer applied to the engagement side of the non-woven or specifically in the more general area where the adhesive tab 8 would be attached. The purpose of the surface modified zone 11 is to bind partially free fibres along their unconnected length to the general bulk of the non-woven material and also coat the outward surface of exposed fibres to present a more homogeneous surface to mate with the adhesive tab.


In FIG. 5a an alternative method is described whereby a separate film material applied to the non-woven material replaces the surface coating. The non-woven components 9, 10 are to be joined by the adhesive tab 8 acting on the filmic layer 12 made of a material such as regenerated cellulose, polypropylene, PVC or polyester bonded to the attachment side 10a of non-woven 10 by such means as an adhesive layer 13.


In FIG. 5b the non-woven components 9, 10 are to be joined by the adhesive tab 8 acting on the filmic zone 12 welded to the attachment side 10a of non-woven 10 by such means for example as Radio Frequency, Ultrasonic or Thermal Impulse welding with, for example, weld detail 14.


In FIG. 5c the configuration and construction is further modified to attach the filmic zone to the reverse side 10b of non-woven 10 and for film or film impregnated non-woven to be accessible on the attachment side. In the simplest of variants a series of apertures, such as illustrated by perforations 15 cut through the non-woven 10, can be arranged to partially reveal the filmic material to the adhesive tab.


A further variant shown in FIG. 5d would provide a filmic zone by virtue of forcing filmic layer material 12 through the non-woven 10 from the reverse to the adhesive tab attachment side in a predetermined melt modified zone 16 whilst in a molten state during a welding technique such as mentioned previously.


The foregoing has described how to prepare the surface of the non-woven to be tolerant to more than a single application of an adhesive medium. In addition it is possible to engineer failure of the closure mechanism by manipulating either the quality of the surface modification or the ratio of surfaces with differing shedding characteristics, either in 2 dimensional or 3 dimensional domains.



FIGS. 6
a-c are sectional views showing the initial concept.


In FIGS. 6a & b, two non-woven components 9, 10 are to be joined by an adhesive tab 8 acting on to a receptive zone 17 on the attachment side 10a of non-woven 10. For descriptive purposes only, the receptive zone 17 is shown as being the same area as the adhesive tab 8.


In FIG. 6c the relationship between closure strength and number of repeated fastenings is graphed. It will be realised that with each closure there is migration of the non-woven fibres from the non-woven to the adhesive tab such that the efficacy of the adhesive bond diminishes as the adhesive media becomes contaminated by shed material. Within several fastening cycles the adhesive bond will degrade below an acceptable minimum level, for example, such as is necessary to resist the impulsive inflation of a Foot Impulse Technology garment.


In the sectional view FIG. 7a similar to FIG. 6 and plan view FIG. 7b, two non-woven components 9, 10 are to be joined by an adhesive tab 8 acting on to a receptive zone 17 on the attachment side 10a of non-woven 10. The receptive zone 17 comprises a surface modified zone 17a and an untreated or normal non-woven surface 17b. For descriptive purposes it should be considered that the area of the surface modified zone 17a is half that of the adhesive tab 8 and that the area of 17a plus 17b are equal to that of 8. In fact 17b is identically the same as the larger surrounding area 10 so in fact need not be specifically defined. Again, for simplification in explaining the process it should be considered that the surface modified zone 17a is essentially non destructive to the tape whereas by comparison the untreated areas 17b or 10 are wholly destructive after separation of a single union.


When the adhesive tab 8 is bonded for the first time, half of the tab area is mated with the surface modified zone 17a and half with the untreated non-woven 17b. In this ideal scenario it is assumed that perfect superimposition is achieved and that the bond strength between the adhesive tab and surface modified area and untreated area are identical although in practice this may not be exactly so. When the closure is opened for the first time half of the adhesive tab separates without deterioration from the surface modified zone whilst the other half separates and is totally destroyed by fibre take up. Should the adhesive tab subsequently be adhered in precisely the same way as the first fit the strength of the bond will be diminished and cannot be greater than 50% of the original value. In practice this ideal will not be attained as perfect superimposition is unlikely and there will be some residual strength in the sacrificial bond between adhesive tab 8 and non-woven 17b and some reduction in strength between the indestructible bond of adhesive tab 8 to surface modified zone 17a. Nevertheless, the closure strength may be engineered and manipulated to deteriorate over a few closure cycles in a controlled manner.


It is clear that other ratios of surface modified zone to untreated non-woven are equally possible and the ratio can be tailored to enhance or diminish the limited durable life of the closure system.



FIG. 8 is a graph showing the effect that variation in the surface modified zone to untreated non-woven ratio has on relative strength over a number of closure cycles. A minimum acceptable strength is also indicated such as, say 35% of maximum strength. Taking the ratio of surface modified zone to untreated non-woven zone as 50:50, the initial strength is 100% after the first closure and 50% after the second for reasons explained previously. Clearly this ratio will continue to allow the closure to function as the relative strength after the second closure exceeds the minimum acceptable strength. However, in comparison if the surface modified zone to untreated non-woven ratio is 25:75 the relative strength is less than the minimum acceptable strength threshold after the second closure and failure will occur in the closure when the Foot Impulse Technology garment is impulsed. For the examples of ratio 50:50 and 75:25 there will be a practical deterioration as explained previously leading to anticipated failure after the third and fourth closures as suggested.



FIG. 9 is a plan view showing that in practice more than a single cell of surface modified zone and untreated or normal non-woven may be utilised. Item 11 is the surface modified zone and 10a the attachment side of the unmodified non-woven 10 of for example the upper 1 being part of the construction of a Foot Impulse Technology garment as referred to earlier. Clearly the ratio and proportions of items 11:10a may be described to provide a linear grid of variable adhesion and ablation on the surface of the garment upon which an adhesive closure tab may be mated.



FIG. 10 is a plan view showing that the grid may be replaced for example by an irregular, or even random, disposition of surface modified zones 11 where the influence of repetition may be significant or non-significant in comparison with the untreated non-woven areas 10a as part of the whole 10 and in comparison with the area of the adhesive closure tab. Whilst the example depicts rectangular and repeatably sized areas 11 and 10a these may also be of other regular forms such as for example squares, circles and hexagons either of singular or multiple sizes or irregular free form shapes of singular or multiple sizes.



FIG. 11 is an isometric view further showing that the surface modified zones and untreated non-woven may be arranged in a non-linear form where the dimensions and relative proportions of each are configured for additional benefit. Surface modified element 17a is significantly larger area than surrounding lands, for example non-woven zone 17b and the next adjacent surface modified element (small) 17c such that preferential adhesion will occur, in this particular example, in the central portion of upper non-woven fabric 10 when closure is made with non-woven 9 incorporating adhesive tab 8. In addition ablation of the adhesive tab may be maximised in areas of relatively large untreated non-woven coverage (large) as shown for example at 17d. One practical benefit of asymmetrical or non-linear apportionment of the adhesive tab closure area is to provide maximum strength to resist the shear force imposed on the closure means by impulsing of a Foot Impulse Technology garment whilst permitting easy peel of the overlying component from the edges should removal be desired.



FIG. 12 is a sectional view illustrating the possibility of adapting the surface modified area to provide differential ablation capability. It is assumed in this eventuality that the surface modified area is of regular size, shape and disposition for simplicity but this is not mandatory.


The non-woven component 10 is processed on the attachment side 10a to provide surface modified elements such as 17e, 17f and 17g where the process is selected either to apply a pre-determined weight or thickness of media onto the non-woven or a fixed allocation of media applied at different pressure to compress the surface fibrous element on the attachment side 10a. Three examples are shown; at 17e the effect is merely to coat or bind the protruding surface fibres a minimal amount shown as 1% (or 99% unbound) to achieve an extremely weakly re-enforced non-woven, at 17f the coating is thicker, either fully encapsulating virtually all the surface fibres or fully compressing the fibres and coating the surface to achieve 99% bound (or 1% free), whilst 17g illustrates the mid point equating to 50% binding. Clearly when an adhesive tab is applied as discussed previously the robust surface modified element of 17f will permit more make and break closures than the weakly bound surface of 17e, or conversely the area of 17e will have a more limiting effect on the durability of the closure than would 17f, whilst a formulation offering the mid range option 17g may provide the desirable life compromise of say, more than 1 but less than 5 closure and open cycles.


In both examples FIGS. 12a and 12b the process may be selected either to apply a pre-determined and constant weight or thickness of media such as at 17e and 17f whereby the method of process application e.g. printing pressure and/or media viscosity would modify the rate of absorption of media by the non-woven component 10. Such a method would permit, for example, design options ranging from a weakly bonded, readily detachable surface modified zone of significant and reliable thickness to a homologous, permanent and irremovable zone entangled with the non-woven component.


Furthermore, such ideas as explained in FIG. 11 could be considered to constitute a 3 dimensional element to the closure mechanism which may or may not be combined with the 2 dimensional arrangements disclosed in FIGS. 7-11.



FIG. 13a is a sectional view and FIG. 13b an exploded isometric view showing a means of obtaining a variable thickness bonding coat form of surface treated zone as previously described in FIG. 4 by printing or applying an ink, varnish, adhesive or similar medium more than once.


Two non-woven components 9, 10 to be joined by an adhesive tab 8 acting on to a surface modified zone 11 on the attachment side 10a of non-woven 10. The surface modification may take the form of ink or adhesive coating applied to the attachment side of the non-woven or specifically in the more general area where the adhesive tab 8 would be attached. Item 11a, the surface modified zone layer 1 medium is applied directly to the attachment side 10a and is applied consistently over the entire area, followed by item 11b, the surface modified zone layer 2 applied in selective areas only, for example as illustrated by perforated holes to produce a general overall covering of variable but controlled thickness, weight or compaction of the surface fibres. As previously this method of 3 dimensional coating is not bounded by any limitation as to the permutations of shape, size or coverage, which in general may be engineered, between zero and total for maximum benefit.


Furthermore, the same method can be employed with the first layer 11a may be a continuous filmic layer and the second layer 11b a perforated filmic layer. In both examples the layers 11a and 11b may be transposed.



FIG. 14 shows a sectional view of non-woven materials 10 with a bonding coat provided by a surface modified zone 11 applied to achieve variable penetration of the coating into the non-woven. The surface modified zone is applied to the non-woven material in conjunction with vacuum apparatus 19. A vacuum pump 20 produces a negative pressure in chamber 21, which in turn is applied through a series of appropriately sized and spaced holes 22 to the atmospheric surface side of the vacuum bed 23. When a media of low viscosity is applied to the attachment side 10a of the non-woven component 10 and a negative pressure selectively applied to the reverse side 10b of a porous material such as a non-woven, the media is drawn into the non-woven in a locally preferential or generally 3 dimensional manner. Clearly, and as explained previously the adhesion and ablation characteristics will be modified in sympathy with the absorption of media into the non-woven.



FIG. 15 is an isometric view illustrating a useful effect that may be used to demonstrate contamination of the adhesive tab to the operator or nurse through repeat closure applications.


It shows an isometric view of two non-woven components 9, 10 to be joined by an adhesive tab 8 acting on to a surface modified zone 11 bonded to the attachment side 10a of non-woven 10. The surface modification may take the form of ink or adhesive coating applied to the attachment side of the non-woven or specifically in the more general area where the adhesive tab 8 would be attached.


In this variant the general surface modified zone 11 is applied, for example as a series of circular dots, surface modified element (dots) 17h that to a degree have an affinity for the adhesive tab 8. Each time a closure is made and then opened between the adhesive tab and surface modified zone an amount of shedding of surface modified element (dots) and surrounding non-woven occurs and is transferred from the untreated non-woven surface 10a and/or surface treated elements 17h to the adhesive tab 8. The surface modified elements (dots) are preferably coloured to contrast with the appearance of the adhesive tab such that whilst the shedding of non-woven onto the adhesive tab may be distinguished by those knowledgeable in the process, the contamination of the adhesive tab by a contrasting colour may be clearly appreciated by all and the level of coloured contamination used to signify the amount of closure degradation.



FIG. 16a is an isometric view showing a further embellishment when the transfer of media is used to convey a message to the operator or nurse.


It shows an isometric view of two non-woven components 9, 10 to be joined by an adhesive tab 8 acting on to a surface modified zone 11 bonded to the attachment side 10a of non-woven 10.


In this variant the surface modified zone 11 is applied, for example as a legend, symbol or icon 24 that to a degree has an affinity for the adhesive tab 8. When closure is made and then opened between the adhesive tab and surface modified zone an amount of shedding of surface modified zone and surrounding non-woven occurs and the legend, icon or symbol is transferred from the attachment side 10a of non-woven surface 10 and/or surface treated zone 11 including descriptive legend 24 to the adhesive tab 8. The descriptive legend is preferably coloured to contrast with the appearance of the adhesive tab such that the information is transferred and clearly legible on the adhesive tab. As a means of disguising a message it may be written as a mirror image and/or obscured as the embedded and weakly bonded text, as alluded to previously, by amalgamation into a general area of coverage provided by a 2 layer surface modified zone.


An alternative approach shown in isometric view FIG. 16b would be to convey the message through removal of media from the surface modified zone, indicated as a ‘reversed out’ marking in natural non-woven colour surrounded by residual unlaminated contrasting media.


A surface modified zone 11 comprises of item 11a, a surface modified layer 1 containing the legend, symbol or icon 24 applied to the attachment side 10a of non-woven 10 and a further layer, item 11b a surface modified zone layer two applied on top of 11a as described previously to achieve a less durable bonding coat in the descriptive area. Alternatively the positions of 11a and 11b may be reversed. Removal of the closure will reveal the legend preferentially on the surface modified zone and/or adhesive tab.



FIG. 17 is an isometric view of the inner and outer surfaces of a short life Foot Impulse Therapy garment and comprises of a non-woven upper 1 formed from the joining of upper skinside 1a to upper outside 1b as described previously. In this variant a pull tab 25 extends from the upper skinside either included as part of the integral profile of item 1a or as an additional joined component. An adhesive tab 8 is secured to the underside of the upper skinside 1a so as to engage with the receptive zone 17 at the other end of the garment and in particular with the surface modified zone 17a when it is fitted around the foot as described previously. In addition further adhesive components are secured to the underside of the pull tab 25, shown for example as two separate but similar components identified as anchor tabs 26, 27, so as to engage with the other end of the garment at the receptive zone 17 but beyond the surface modified zone 17a, generally on to the untreated or normal non-woven element 17b.


The essential improvement in this variant is to separate the elements of the closure into two distinct closure zones thereby offering a combined dual closure system.


In the first closure zone the integrity of the garment to resist the stress of rapid inflation is accomplished by closure of the adhesive tab 8 onto the surface modified zone 17a. In this instance the bond between adhesive tab 8 and surface modified zone 17a is engineered for maximum strength coupled with the ability to repeatedly close and open several times without significant deterioration of the bond strength, that is within the intended short life of the garment a multiple use of this closure is desirable without performance being substantially compromised.


In the second closure zone the limited durability of the garment is defined by closure of either or both anchor tabs 26, 27 on to the untreated or normal non-woven element 17b. In this instance, and in complete contrast to the performance of the first closure zone, the bond between anchor tabs 26, 27 and untreated or normal non-woven element 17b is engineered for adequate strength coupled with the ability for preferably single use closure only.


On separation, the anchor tabs 26, 27 are contaminated by pick-up of fibre shed from the surface of the non-woven thus reducing the adhesive bond strength should re-closure be attempted. As shown, the possibility exists for two satisfactory closures by utilising first anchor tab 26 alone and once this has been closed and re-opened additionally anchor tab 27. Furthermore, the adhesive strength may be engineered to offer a third closure application by using both anchor tabs 26, 27 together one more time provided their combined strength is sufficient. It will be appreciated that various combination of single and multiple anchors or orders of application will provide a limited durability feature and the method need not also be limited to the two anchor tabs referred to for simplicity.


Throughout this description no mention has been made of release liners to protect the surface of the adhesive prior to adhesion as it is presumed someone skilled in the art would be knowledgeable of this requirement.


As well as providing the life limiting feature of this combined dual closure system the anchor tab(s) perform the essential role of ensuring that the hemispherical edge of the adhesive tab 8 does not begin to lift through peel as a result of inflating the garment. Provision of a pull tab remote from the hemispherical end allows the stress of inflation to be reduced by extension along the length of the pull tab, the pull tab to be attached to the untreated or normal non-woven element 17b in an area of the upper 1 that is at lower stress and expansion, than for example the area of the inflation bladder, and an anchoring or holding down effect on the hemispherical edge of the adhesive tab 8 when the garment is fitted and closed as a hoop around the foot.


The preceding configuration with reference to FIG. 17 is illustrated with reference to FIG. 18a and FIG. 18d. FIG. 18a is a simplified cross sectional drawing where for convenience the section through a foot is considered to be circular. The upper 1, comprising a joined upper skinside 1a and upper outside 1b that may be closed as a hoop with adhesive tab 8. When a bladder 28 is inflated the hoop stress developed in the upper 1 applies a shear force between the adhesive tab 8 and its bond to the upper skinside 1a and the closure between the adhesive tab 8 and the upper outside 1b. Furthermore a differential exists between a lower hoop stress applied through the upper skinside and a higher hoop stress value applied through the upper outside causing the outermost edge of the adhesive tab to peel and curl clockwise (in the example depicted). Over time this closure will gradually open and through continued inflation and/or patient movement and interaction with bedding detach and become defective.



FIG. 18b is a simplified cross sectional drawing where for convenience the section through a foot is considered to be circular. The upper 1, comprising a joined upper skinside 1a and upper outside 1b closed as a hoop with adhesive tab 8 and additionally anchored by anchor tab 26 and/or anchor tab 27, on pull tab 25. When a bladder 28 is inflated the hoop stress developed in the upper 1 is applied as before but the effect of items 25, 26 and/or 27 is to provide an inward securing force holding the outmost end of adhesive tab 8 bonded to upper outside 1b to prevent the process of peel, curl, detachment and malfunction occurring.



FIG. 19a is a preferred arrangement of a complete closure system for a short life Foot Impulse Technology garment shown in plan form viewed from the outside or non-foot contact side. See also; FIG. 2 for general outline and attachment to the foot and compare those features using the same reference numerals. The right hand side of the view depicts the adhesive closure dorsum 5 and the left side the receptive zone 17 which when fitted around the foot as a hoop and secured together constitute a limited durability closure.


The upper 1, comprises an upper skinside 1a and upper outside 1b joined around the main periphery by weld detail upper 14a. Both upper components are of similar profile shape except that pull tab 25 is only included on the upper skinside.


At the adhesive closure dorsum 5 end of the garment the periphery is extended and further locally joined in the area of the anchor tab 26, by weld detail anchor tab 14b. An adhesive tab 8 of approximately hemispherical shape is adhered to the reverse side of the upper 1, specifically to the skinside of upper skinside 1a. In this variant the general and larger hemispherical shape is further extended from the hemispherical edge by a smaller hemispherical element. The anchor tab 26, is adhered to the extension except for the distal finger lift portion, the pull tab 25. The anchor tab 26, may be a separate component or included as part of the adhesive tab 8. The adhesive tab 8 and anchor tab 26, will be explained in more detail with reference to FIG. 19b.


Importantly the weld detail upper 14a and weld detail anchor tab 14b are two separate entities spaced to allow a stress relieving slit 29 to be positioned between. The stress relieving slit 29 is pierced completely through the thickness of the upper outside 1b over the majority of the width of the pull tab 25 leaving sufficient non-woven land attached only to prevent detachment of the pull tab element from the general upper outside, for manufacturing convenience. It should also be recognised that the stress relieving slit 29 does not penetrate the upper skinside 1a. The adhesive closure dorsum 5 will be explained in more detail with reference to FIG. 19c.



FIG. 19d is a cross sectional drawing showing the receptive zone 17 end of the garment with the upper skinside 1a joined to the upper outside 1b by weld detail upper 14a as stated previously.


The upper skinside is processed over approximately one third of the upper area as shown on the external or attachment side 10a by application of a surface modified element 17a. Surface modified element 17a is located so as to coincide with the position of the adhesive closure dorsum 5 when the garment is fitted to the foot as a hoop and for practical purposes is oversized compared with, for example adhesive tab 8, to accommodate a range of foot sizes and ergonomic shapes.


In detail the receptive zone 17 comprises of several features each having a different performance characteristic.


The general area is a surface modified element 17a which provides good receptivity with the adhesive tab 8 and anchor tab 26 and should be considered as being able to withstand multiple closure and opening cycles of the adhesive tabs without significant deterioration of the bond strength.


Within the surface modified element 17a are areas or zones of untreated or normal non-woven element 17b which by further reference to FIG. 19a are illustrated in this example as being of ring form, regularly spaced across the general area. As disclosed previously the form, disposition and quantity or area of untreated or normal non-woven element 17b is one variable used to modify performance. The function of the untreated or normal or untreated element 17b is to provide adhesion with the adhesive tab 8 and anchor tab 26 for the first closure and thereafter to inhibit the performance of the adhesive bond by clogging the adhesive, either preventing or reducing re-adhesion in that previously bonded region. In comparison with the general area specified for multiple closures this element is intended to be essentially single use.


The untreated or normal non-woven element 17b, contained by the receptive zone 17, may be further processed to provide surface treated elements (dots) 17h adhered to the non-woven or alternatively or additionally applied directly to the surface modified element 17a. These features are shown in repetitive layout FIG. 19a but may take other forms as described previously. The purpose of surface treated elements (dots) 17h is to provide adhesion with the adhesive tab 8 and anchor tab 26 for the first closure and thereafter to inhibit the performance of the adhesive bond by clogging the adhesive, either preventing or reducing re-adhesion in that previously bonded region and to reveal the fibre transfer from the non-woven component to the adhesive components in a clear way to the user. Where it is desirable to use a white coloured non-woven material in conjunction with a clear, natural, white or light coloured adhesive, deposition of the non-woven fibres on to the adhesive may be difficult to recognise by the nurse or user. If the surface treated elements (dots) 17h are of a contrasting colour a viable means of indicating that the limited durability closure has been closed and opened at least once is provided. Furthermore since in practical application not all of an engaged dot area would be expected to transfer on a first event and a second closure is unlikely to absolutely coincide with the original closure more contrasting material will be transferred with each opening of the closure to provide an indication of the number of closure/opening cycles completed.


Other combinations of limited durability closure can be realised with different ratios of multiple to single use areas, with or without tell tale markers on either elements.



FIG. 19b shows in plan view the detail of the adhesive closure element comprising the adhesive tab portion 8 and the anchor tab 26 which may be produced as one entity of particular adhesive quality or as a combination of 2 parts either of same or different adhesive quality and the non adhesive pull tab 25.



FIG. 19c is a cross sectional view of the adhesive closure dorsum 5 comprising the upper skinside is joined to the upper outside 1b by weld detail upper 14a and in the area of anchor tab 26, by weld detail anchor tab 14b. Stress relieving slit 29 is positioned between the two weld areas and is cut through the upper outside 1b only. The adhesive tab 8 and anchor tab 26, shown coincident in this example, are attached to the upper skinside 1a on the skin side 10c. The pull tab 25 extends from the anchor tab area to provide an accessible finger lift portion which may be gripped to separate the limited durability closure prior to removal of the garment from the foot by first peeling the anchor tab 26 from the receptive zone followed by the adhesive tab.


As described previously the combination of adhesive tab, anchor tab and stress relieving slit serve to provide an inward securing force holding the outmost end of adhesive tab 8 bonded to upper outside 1b via receptive zone 17 to prevent the process of peel, curl, detachment and malfunction occurring during the treatment of the patient.


As a final variant, FIG. 20 shows an isometric view of a revised arrangement having two non-woven components 9, 10 to be joined by a composite adhesive tab 30 acting directly onto the attachment side 10a of non-woven 10. The composite adhesive tab comprises re-useable elements 30a and degradable elements 30b. Item(s) 30a are engineered to be selectively re-applicable to the non-woven with low take up of fibrous materials whereas item(s) 30b is selected for its initial strength and ability to be readily contaminated by shed fibres from the non-woven material. In this way the relative strength may be controlled to have limited durability irrespective of preparation of the non-woven surface.

Claims
  • 1. A method of providing a limited durability fastening for a garment comprising providing one fastening garment element of the garment with an adhesive tab and/or adhesively treated area, providing another fastening garment element of the garment with a contact zone or zones formed of a material capable of degrading the adhesive of the tab or treated area upon contact therewith, modifying the garment material at said contact zone or zones to control the degradation of the adhesive tab or adhesively treated area when contact is made therebetween thereby to determine the permissible number of make and break closures of the fastening having a predetermined contact strength, wherein an aperture or apertures are provided in said one garment fastening element as a means of relieving the stress in the limited durability fastening, and providing a non-woven material as the material capable of degrading the adhesive tab or treated area, wherein the garment material is modified by applying a bonding coat in the form of a vapour phase media.
  • 2. A method as claimed in claim 1 wherein the application of the bonding coat in the form of the vapour phase media is applied under the influence of negative pressure to the reverse side of the non-woven material in a predetermined pattern and varying the negative pressure to determine the final thickness, weight or ingress of the bonding coat on the non-woven material.
  • 3. A method as claimed in claim 2 further including applying an obscured or hidden textual symbolic or iconic message on one or more of said garment elements on the adhesive tab, adhesively treated area or non-woven material by transfer or removal of defining elements.
  • 4. A method as claimed in claim 3 further including providing a visual indication of the limited number of make and break closures by contrasting contamination of the adhesive tab or adhesively treated area.
  • 5. A method as claimed in claim 4 wherein the contrasting coloured contamination is provided by removal depletion or deposition of contrasting coloured fibrous material from the contact zone or zones.
  • 6. A method as claimed in claim 4 wherein contrasting contamination is provided by indication of the cumulative degree of contamination of the materials in the attachment area.
  • 7. A method as claimed in claim 1 including degrading a closure strength of the fastening at least 50% after 4 make and break closures.
  • 8. A method as claimed in claim 1 wherein modifying the garment material comprises changing an adhesive degrading surface characteristic of the garment material in the contact zone or zones.
Priority Claims (1)
Number Date Country Kind
0515294.7 Jul 2005 GB national
CROSS-REFERENCE TO RELATED APPLICATION

This application is a divisional of U.S. Ser. No. 11/996,995, filed Feb. 7, 2008, which is the National Stage of International Application No. PCT/GB2006/002674, filed Jul. 19, 2006 and published as WO2007/07012812, which claims priority from Great Britain Application No. 0515294.7, filed Jul. 26, 2005, and the entire contents of each of these applications is incorporated herein by reference.

US Referenced Citations (655)
Number Name Date Kind
908959 Cooke Jan 1909 A
910689 Kelly et al. Jan 1909 A
1510482 Kramer Oct 1924 A
1608239 Rosett Nov 1926 A
2199408 Liberte May 1940 A
2250617 Argentin Jul 1941 A
2489388 Rubin Nov 1949 A
2533504 Poor Dec 1950 A
2638915 Mitchell May 1953 A
2676587 Corcoran Apr 1954 A
2694395 Brown Nov 1954 A
2853998 Emerson Sep 1958 A
2880721 Corcoran Apr 1959 A
2896612 Bates et al. Jul 1959 A
2998817 Armstrong Sep 1961 A
3164152 Nicoll Jan 1965 A
3245405 Gardner Apr 1966 A
3288132 Meredith Nov 1966 A
3351055 Gottfried Nov 1967 A
3454010 Lilligren et al. Jul 1969 A
3469769 Guenther Sep 1969 A
3473527 Spiro Oct 1969 A
3504675 Bishop, Jr. Apr 1970 A
3561435 Nicholson Feb 1971 A
3568227 Dunham Mar 1971 A
3606880 Ogle, Jr. Sep 1971 A
3638334 Malikowski Feb 1972 A
3701173 Whitney Oct 1972 A
3728875 Hartigan et al. Apr 1973 A
3760795 Adelhed Sep 1973 A
3770040 De Cicco Nov 1973 A
3771519 Haake Nov 1973 A
3786805 Tourin Jan 1974 A
3824992 Nicholson et al. Jul 1974 A
3826249 Lee et al. Jul 1974 A
3862629 Rotta Jan 1975 A
3868952 Hatton Mar 1975 A
3877426 Nirschl Apr 1975 A
3878839 Norton et al. Apr 1975 A
3899210 Samhammer et al. Aug 1975 A
3901221 Nicholson et al. Aug 1975 A
3906937 Aronson Sep 1975 A
3920006 Lapidus Nov 1975 A
D239981 Arluck et al. May 1976 S
3955565 Johnson, Jr. May 1976 A
4013069 Hasty Mar 1977 A
4029087 Dye et al. Jun 1977 A
4030488 Hasty Jun 1977 A
4054129 Byars et al. Oct 1977 A
4066084 Tillander Jan 1978 A
4076022 Walker Feb 1978 A
4091804 Hasty May 1978 A
4116236 Albert Sep 1978 A
4146021 Brosseau et al. Mar 1979 A
4149529 Copeland et al. Apr 1979 A
4149541 Gammons et al. Apr 1979 A
4153050 Bishop et al. May 1979 A
4156425 Arkans May 1979 A
4197837 Tringali et al. Apr 1980 A
4198961 Arkans Apr 1980 A
4201203 Applegate May 1980 A
4202312 Mori et al. May 1980 A
4202325 Villari et al. May 1980 A
4206751 Schneider Jun 1980 A
4207875 Arkans Jun 1980 A
4207876 Annis Jun 1980 A
4219892 Rigdon Sep 1980 A
4253449 Arkans et al. Mar 1981 A
D259058 Marshall Apr 1981 S
4267611 Agulnick May 1981 A
4270527 Peters et al. Jun 1981 A
4280485 Arkans Jul 1981 A
4294238 Woodford Oct 1981 A
4294240 Thill Oct 1981 A
4300245 Saunders Nov 1981 A
4308862 Kalmar Jan 1982 A
4311135 Brueckner et al. Jan 1982 A
4320746 Arkans et al. Mar 1982 A
4343302 Dillon Aug 1982 A
4351872 Brosseau et al. Sep 1982 A
4352253 Oswalt Oct 1982 A
4355632 Sandman Oct 1982 A
4363125 Brewer et al. Dec 1982 A
4372297 Perlin Feb 1983 A
4375217 Arkans et al. Mar 1983 A
4379217 Youmans Apr 1983 A
4402312 Villari et al. Sep 1983 A
4408599 Mummert Oct 1983 A
4417587 Ichinomiya et al. Nov 1983 A
4425912 Harper Jan 1984 A
4437269 Shaw Mar 1984 A
4442834 Tucker et al. Apr 1984 A
4445505 Labour et al. May 1984 A
4453538 Whitney Jun 1984 A
4522197 Hasegawa Jun 1985 A
4531516 Poole et al. Jul 1985 A
4547906 Nishida et al. Oct 1985 A
4547919 Wang Oct 1985 A
4552821 Gibbard et al. Nov 1985 A
4580816 Campbell et al. Apr 1986 A
4583255 Mogaki et al. Apr 1986 A
4593692 Flowers Jun 1986 A
4597384 Whitney Jul 1986 A
4614179 Gardner et al. Sep 1986 A
4614180 Gardner et al. Sep 1986 A
4624244 Taheri Nov 1986 A
4624248 Poole et al. Nov 1986 A
4650452 Jensen Mar 1987 A
4657003 Wirtz Apr 1987 A
4682588 Curlee Jul 1987 A
4696289 Gardner et al. Sep 1987 A
4699424 Andres et al. Oct 1987 A
4702232 Gardner et al. Oct 1987 A
4703750 Sebastian et al. Nov 1987 A
4706658 Cronin Nov 1987 A
4721101 Gardner et al. Jan 1988 A
4722332 Saggers Feb 1988 A
4730606 Leininger Mar 1988 A
4753649 Pazdernik Jun 1988 A
4762121 Shienfeld Aug 1988 A
4773397 Wright et al. Sep 1988 A
4805620 Meistrell Feb 1989 A
4809684 Gardner et al. Mar 1989 A
4827912 Carrington et al. May 1989 A
4832010 Lerman May 1989 A
RE32939 Gardner et al. Jun 1989 E
RE32940 Gardner et al. Jun 1989 E
4836194 Sebastian et al. Jun 1989 A
4836691 Suzuki et al. Jun 1989 A
4841956 Gardner et al. Jun 1989 A
D302301 Robinette-Lehman Jul 1989 S
4846160 Gardner et al. Jul 1989 A
4846189 Sun Jul 1989 A
4869265 McEwen Sep 1989 A
4872448 Johnson, Jr. Oct 1989 A
4876788 Steer et al. Oct 1989 A
4883073 Aziz Nov 1989 A
4886053 Neal Dec 1989 A
4898160 Brownlee Feb 1990 A
4913136 Chong et al. Apr 1990 A
4938207 Vargo Jul 1990 A
4938208 Dye Jul 1990 A
4938226 Danielsson et al. Jul 1990 A
4945571 Calvert Aug 1990 A
4947834 Kartheus et al. Aug 1990 A
4957105 Kurth Sep 1990 A
4960115 Ranciato Oct 1990 A
4964402 Grim et al. Oct 1990 A
4979953 Spence Dec 1990 A
4985024 Sipinen Jan 1991 A
4989273 Cromartie Feb 1991 A
4997452 Kovach et al. Mar 1991 A
5007411 Dye Apr 1991 A
5014681 Neeman et al. May 1991 A
5022387 Hasty Jun 1991 A
5031604 Dye Jul 1991 A
5048536 McEwen Sep 1991 A
5052377 Frajdenrajch Oct 1991 A
5062414 Grim Nov 1991 A
5069219 Knoblich Dec 1991 A
5071415 Takemoto Dec 1991 A
5080951 Guthrie Jan 1992 A
5082284 Reed Jan 1992 A
5109832 Proctor et al. May 1992 A
5117812 McWhorter Jun 1992 A
5120300 Shaw Jun 1992 A
5135473 Epler et al. Aug 1992 A
5139475 Robicsek Aug 1992 A
5139476 Peters Aug 1992 A
5139479 Peters Aug 1992 A
5146932 McCabe Sep 1992 A
5156629 Shane et al. Oct 1992 A
5158541 McCurley Oct 1992 A
5168576 Krent et al. Dec 1992 A
5172689 Wright Dec 1992 A
D332495 Lake Jan 1993 S
5179941 Siemssen et al. Jan 1993 A
5181522 McEwen Jan 1993 A
5186163 Dye Feb 1993 A
5193549 Bellin et al. Mar 1993 A
5211162 Gillen, Jr. et al. May 1993 A
5226245 Lamont Jul 1993 A
5226564 Steer et al. Jul 1993 A
5228478 Kleisle Jul 1993 A
5230335 Johnson, Jr. et al. Jul 1993 A
5245990 Bertinin Sep 1993 A
5259397 McCabe Nov 1993 A
5261871 Greenfield Nov 1993 A
5263473 McWhorter Nov 1993 A
5275588 Matsumoto et al. Jan 1994 A
5277695 Johnson, Jr. et al. Jan 1994 A
5277697 France et al. Jan 1994 A
5288286 Davis Feb 1994 A
5312431 McEwen May 1994 A
5314455 Johnson, Jr. et al. May 1994 A
5334135 Grim et al. Aug 1994 A
5342285 Dye Aug 1994 A
5354260 Cook Oct 1994 A
5378224 Billotti Jan 1995 A
5383894 Dye Jan 1995 A
5383919 Kelly et al. Jan 1995 A
5385538 Mann Jan 1995 A
5389065 Johnson, Jr. Feb 1995 A
5391141 Hamilton Feb 1995 A
5399153 Caprio, Jr. et al. Mar 1995 A
5403265 Berguer et al. Apr 1995 A
5406661 Pekar Apr 1995 A
5407421 Goldsmith Apr 1995 A
D358216 Dye May 1995 S
5413142 Johnson et al. May 1995 A
5413582 Eaton May 1995 A
5419757 Daneshvar May 1995 A
5425701 Oster et al. Jun 1995 A
5435009 Schild et al. Jul 1995 A
5437595 Smith Aug 1995 A
5437610 Cariapa et al. Aug 1995 A
5441533 Johnson et al. Aug 1995 A
5443440 Tumey et al. Aug 1995 A
5449341 Harris Sep 1995 A
5449379 Hadtke Sep 1995 A
5450858 Zablotsky et al. Sep 1995 A
5451201 Prengler Sep 1995 A
5453081 Hansen Sep 1995 A
5455969 Pratson et al. Oct 1995 A
5458265 Hester et al. Oct 1995 A
5462517 Mann Oct 1995 A
5466250 Johnson, Jr. et al. Nov 1995 A
5470156 May Nov 1995 A
5478119 Dye Dec 1995 A
5489252 May Feb 1996 A
5489259 Jacobs et al. Feb 1996 A
5496262 Johnson, Jr. et al. Mar 1996 A
5503620 Danzger Apr 1996 A
5511552 Johnson Apr 1996 A
5513658 Goseki May 1996 A
5514081 Mann May 1996 A
5514155 Daneshvar May 1996 A
5527267 Billotti Jun 1996 A
5554105 Taylor Sep 1996 A
D376013 Sandman et al. Nov 1996 S
5575762 Peeler et al. Nov 1996 A
5578055 McEwen Nov 1996 A
5584798 Fox Dec 1996 A
5588954 Ribando et al. Dec 1996 A
5588955 Johnson, Jr. et al. Dec 1996 A
5588956 Billotti Dec 1996 A
5591200 Cone et al. Jan 1997 A
5591337 Lynn et al. Jan 1997 A
5603690 Barry Feb 1997 A
5609570 Lamont Mar 1997 A
5620411 Schumann et al. Apr 1997 A
5622113 Hansen Apr 1997 A
5626556 Tobler et al. May 1997 A
5626557 Mann May 1997 A
5634889 Gardner et al. Jun 1997 A
5637106 Mitchell et al. Jun 1997 A
5640714 Tanaka Jun 1997 A
5649954 McEwen Jul 1997 A
5653244 Shaw Aug 1997 A
D383547 Mason et al. Sep 1997 S
5664270 Bell et al. Sep 1997 A
5669872 Fox Sep 1997 A
5673028 Levy Sep 1997 A
5674262 Tumey Oct 1997 A
5678558 Johnson Oct 1997 A
5695453 Neal Dec 1997 A
5704999 Lukich et al. Jan 1998 A
5711757 Bryant Jan 1998 A
5711760 Ibrahim et al. Jan 1998 A
5717996 Feldmann Feb 1998 A
5720739 Hilston et al. Feb 1998 A
5725485 Ribando et al. Mar 1998 A
5728055 Sebastian Mar 1998 A
5728057 Ouellette et al. Mar 1998 A
5730710 Eichhorn et al. Mar 1998 A
5733304 Spence Mar 1998 A
5741295 McEwen Apr 1998 A
5746213 Marks May 1998 A
5759167 Shields et al. Jun 1998 A
5765298 Potter et al. Jun 1998 A
5769800 Gelfand et al. Jun 1998 A
5769801 Tumey et al. Jun 1998 A
5772880 Lynn et al. Jun 1998 A
5790998 Crescimbeni Aug 1998 A
5795312 Dye Aug 1998 A
5797851 Byrd Aug 1998 A
5823981 Grim et al. Oct 1998 A
5830164 Cone et al. Nov 1998 A
5833639 Nunes et al. Nov 1998 A
5840049 Tumey et al. Nov 1998 A
5843007 McEwen et al. Dec 1998 A
D403775 Davis et al. Jan 1999 S
D405884 Roper Feb 1999 S
5876359 Bock et al. Mar 1999 A
5891065 Cariapa et al. Apr 1999 A
5894682 Broz Apr 1999 A
D411301 Hampson et al. Jun 1999 S
5916183 Reid Jun 1999 A
5925010 Caprio, Jr. Jul 1999 A
5926850 Han Jul 1999 A
5931797 Tumey et al. Aug 1999 A
5938628 Oguri et al. Aug 1999 A
5951502 Peeler et al. Sep 1999 A
5957872 Flick Sep 1999 A
5966763 Thomas et al. Oct 1999 A
5968072 Hite et al. Oct 1999 A
5970519 Weber Oct 1999 A
5976099 Kellogg Nov 1999 A
5976300 Buchanan et al. Nov 1999 A
5988704 Ryhman Nov 1999 A
5989204 Lina Nov 1999 A
5991654 Tumey et al. Nov 1999 A
5997495 Cook et al. Dec 1999 A
5997981 McCormack et al. Dec 1999 A
6001119 Hampson et al. Dec 1999 A
6007559 Arkans Dec 1999 A
6010471 Ben-Noon Jan 2000 A
6021780 Darby Feb 2000 A
6036718 Ledford et al. Mar 2000 A
6048326 Davis et al. Apr 2000 A
6051016 Mesaros et al. Apr 2000 A
6056713 Hayashi May 2000 A
6062244 Arkans May 2000 A
6066217 Dibble et al. May 2000 A
6076193 Hood Jun 2000 A
6080120 Sandman et al. Jun 2000 A
D428153 Davis Jul 2000 S
6110135 Madow et al. Aug 2000 A
6120469 Bruder Sep 2000 A
6126683 Momtaheni Oct 2000 A
6129688 Arkans Oct 2000 A
6129695 Peters et al. Oct 2000 A
6134720 Foreman Oct 2000 A
6135116 Vogel et al. Oct 2000 A
6145143 Hicks et al. Nov 2000 A
6149600 Poorman-Ketchum Nov 2000 A
6149616 Szlema et al. Nov 2000 A
6152495 Hoffmann et al. Nov 2000 A
6152893 Pigg et al. Nov 2000 A
6168539 Maina Jan 2001 B1
6171271 Hörnberg Jan 2001 B1
6179796 Waldridge Jan 2001 B1
6197045 Carson Mar 2001 B1
6203510 Takeuchi et al. Mar 2001 B1
6209159 Murphy Apr 2001 B1
6212719 Thomas et al. Apr 2001 B1
6227275 Dibble et al. May 2001 B1
6231507 Zikorus et al. May 2001 B1
6231532 Watson et al. May 2001 B1
6245023 Clemmons Jun 2001 B1
6254554 Turtzo Jul 2001 B1
6257626 Campau Jul 2001 B1
6257627 Fujiwara et al. Jul 2001 B1
6260201 Rankin Jul 2001 B1
6273866 Thomas et al. Aug 2001 B2
6290662 Morris et al. Sep 2001 B1
6290664 Nauert Sep 2001 B1
6296617 Peeler et al. Oct 2001 B1
6315745 Kloecker Nov 2001 B1
6319215 Manor et al. Nov 2001 B1
6322530 Johnson, Jr. et al. Nov 2001 B1
6336935 Davis et al. Jan 2002 B1
6338723 Carpenter et al. Jan 2002 B1
6349506 Pace et al. Feb 2002 B1
6358219 Arkans Mar 2002 B1
6361496 Zikorus et al. Mar 2002 B1
6368357 Schon et al. Apr 2002 B1
6375633 Endress et al. Apr 2002 B1
6385778 Johnson May 2002 B1
6385864 Sell, Jr. et al. May 2002 B1
6387065 Tumey May 2002 B1
6402879 Tawney et al. Jun 2002 B1
6409691 Dakin et al. Jun 2002 B1
6421859 Hicks et al. Jul 2002 B1
6423053 Lee Jul 2002 B1
6436064 Kloecker Aug 2002 B1
6440093 McEwen et al. Aug 2002 B1
6447460 Zheng et al. Sep 2002 B1
6447467 Barak Sep 2002 B1
6463934 Johnson, Jr. et al. Oct 2002 B1
6468237 Lina Oct 2002 B1
6478757 Barak Nov 2002 B1
6478761 Bracamonte-Sommer Nov 2002 B2
6488643 Tumey et al. Dec 2002 B1
6493568 Bell et al. Dec 2002 B1
6494852 Barak et al. Dec 2002 B1
6508205 Zink Jan 2003 B1
6520926 Hall Feb 2003 B2
6526597 Shepard Mar 2003 B1
6527727 Itonaga et al. Mar 2003 B2
6537298 Dedo Mar 2003 B2
6540707 Stark et al. Apr 2003 B1
6544202 McEwen et al. Apr 2003 B2
6549748 Miura Apr 2003 B2
6551280 Knighton et al. Apr 2003 B1
6554785 Sroufe et al. Apr 2003 B1
6557704 Randolph May 2003 B1
6558338 Wasserman May 2003 B1
6562060 Momtaheni May 2003 B1
6589267 Hui Jul 2003 B1
6589534 Shaul et al. Jul 2003 B1
6592534 Rutt et al. Jul 2003 B1
6593508 Harder Jul 2003 B1
6598249 Pajanacci et al. Jul 2003 B2
D478995 Cipra et al. Aug 2003 S
6616622 Barberio Sep 2003 B1
6618859 Kadymir et al. Sep 2003 B1
6629941 Ishibashi et al. Oct 2003 B1
6645165 Waldridge et al. Nov 2003 B2
D484986 Cipra et al. Jan 2004 S
6676614 Hansen et al. Jan 2004 B1
6682547 McEwen et al. Jan 2004 B2
6685661 Peled Feb 2004 B2
6719711 Islava Apr 2004 B1
6726641 Chiang et al. Apr 2004 B2
6746470 McEwen et al. Jun 2004 B2
6757516 Miura Jun 2004 B2
6762337 Boukanov et al. Jul 2004 B2
6762338 Harder Jul 2004 B2
6842915 Turner et al. Jan 2005 B2
6846294 Rastegar et al. Jan 2005 B2
6846295 Ben-Nun Jan 2005 B1
6849057 Satou et al. Feb 2005 B2
6852089 Kloecker et al. Feb 2005 B2
6860862 Waldridge et al. Mar 2005 B2
6862989 Belanger et al. Mar 2005 B2
6866636 Inoue et al. Mar 2005 B2
6869409 Rothman et al. Mar 2005 B2
D506553 Tesluk Jun 2005 S
6945944 Kuiper et al. Sep 2005 B2
D510626 Krahner et al. Oct 2005 S
6966884 Waldridge et al. Nov 2005 B2
6973690 Muci et al. Dec 2005 B2
6984215 Shah et al. Jan 2006 B2
6991613 Sensabaugh Jan 2006 B2
7011640 Patterson et al. Mar 2006 B2
7022096 Alfieri Apr 2006 B1
7041074 Averianov et al. May 2006 B1
7044924 Roth et al. May 2006 B1
7048703 Riach May 2006 B2
7063676 Barak et al. Jun 2006 B2
7090500 Guttman Aug 2006 B1
7104967 Rothman et al. Sep 2006 B2
D533668 Brown Dec 2006 S
7166077 Millay et al. Jan 2007 B2
7214202 Vogel et al. May 2007 B1
7217249 Scott May 2007 B2
D545972 Wieringa et al. Jul 2007 S
7237272 Botcher Jul 2007 B2
7238080 Gimble Jul 2007 B2
7244483 Tawney et al. Jul 2007 B2
7258676 Calderon et al. Aug 2007 B2
D550367 Nash Sep 2007 S
7276037 Ravikumar Oct 2007 B2
7276039 Garelick et al. Oct 2007 B2
7278980 Garelick et al. Oct 2007 B1
7282038 Gillis et al. Oct 2007 B2
7285103 Nathanson Oct 2007 B2
7288076 Grim et al. Oct 2007 B2
7297128 Binder et al. Nov 2007 B2
7300410 Weber Nov 2007 B1
7303539 Binder et al. Dec 2007 B2
7306568 Diana Dec 2007 B2
7310847 Bolkan et al. Dec 2007 B2
7318812 Taylor et al. Jan 2008 B2
D562461 Nash Feb 2008 S
D562462 Muir et al. Feb 2008 S
7326227 Dedo et al. Feb 2008 B2
7329232 Lipshaw et al. Feb 2008 B2
7351217 Scherpenborg Apr 2008 B2
7353770 Sanguinetti Apr 2008 B2
7354410 Perry et al. Apr 2008 B2
7354411 Perry et al. Apr 2008 B2
7374550 Hansen et al. May 2008 B2
D577124 Freeland et al. Sep 2008 S
7424936 McClellan Sep 2008 B2
7442175 Meyer et al. Oct 2008 B2
D580553 Nash Nov 2008 S
7465283 Grim et al. Dec 2008 B2
7468048 Meehan Dec 2008 B2
7473816 Hall Jan 2009 B2
D594561 Freeland et al. Jun 2009 S
7543399 Kilgore et al. Jun 2009 B2
7556707 Giori Jul 2009 B2
7559908 Ravikumar Jul 2009 B2
7578799 Thorsteinsson et al. Aug 2009 B2
7591796 Barak et al. Sep 2009 B1
7591797 Hakonson et al. Sep 2009 B2
7597675 Ingimundarson et al. Oct 2009 B2
7615027 Nordt, III et al. Nov 2009 B2
7618384 Nardi et al. Nov 2009 B2
7618389 Nordt, III et al. Nov 2009 B2
7625348 Young et al. Dec 2009 B2
7637879 Barak et al. Dec 2009 B2
D608006 Avitable et al. Jan 2010 S
7654117 Barnett Feb 2010 B2
7670306 Nordt, III et al. Mar 2010 B2
7691084 Knighton et al. Apr 2010 B2
7748090 Seth et al. Jul 2010 B2
7749182 Gramza et al. Jul 2010 B2
7758607 McEwen et al. Jul 2010 B2
7766890 Ito et al. Aug 2010 B2
7771376 Roth et al. Aug 2010 B2
7780614 Bruce et al. Aug 2010 B2
7780698 McEwen et al. Aug 2010 B2
7803358 Gordan et al. Sep 2010 B2
7827624 Cole Nov 2010 B1
7871387 Tordella et al. Jan 2011 B2
7874997 Jaccard Jan 2011 B2
7882568 Fee Feb 2011 B2
7931606 Meyer Apr 2011 B2
7967766 Ravikumar Jun 2011 B2
7976487 Gramza et al. Jul 2011 B2
8002721 Bretl et al. Aug 2011 B2
8016778 Brown et al. Sep 2011 B2
8016779 Brown et al. Sep 2011 B2
8021388 Brown et al. Sep 2011 B2
8029450 Brown et al. Oct 2011 B2
8029451 Meyer et al. Oct 2011 B2
8034007 Avitable et al. Oct 2011 B2
8034013 Winkler Oct 2011 B2
8070699 Avitable et al. Dec 2011 B2
8109892 Brown et al. Feb 2012 B2
8114117 Avitable Feb 2012 B2
8128584 Brown Mar 2012 B2
8177734 Vess May 2012 B2
8235923 Avitable et al. Aug 2012 B2
8419666 Liu et al. Apr 2013 B2
20010018564 Manor et al. Aug 2001 A1
20020042585 Kloecker Apr 2002 A1
20020068886 Lin Jun 2002 A1
20020069731 Soucy Jun 2002 A1
20020115949 Kuslich et al. Aug 2002 A1
20020121235 Carpenter et al. Sep 2002 A1
20030018313 Tanzer et al. Jan 2003 A1
20030083605 Edmund May 2003 A1
20030130644 Baker Jul 2003 A1
20030139255 Lina Jul 2003 A1
20030199922 Buckman Oct 2003 A1
20040010212 Kuiper et al. Jan 2004 A1
20040039317 Souney et al. Feb 2004 A1
20040039413 Akerfeldt et al. Feb 2004 A1
20040054306 Roth et al. Mar 2004 A1
20040068290 Bates et al. Apr 2004 A1
20040097860 Tauber May 2004 A1
20040158283 Shook et al. Aug 2004 A1
20040158285 Pillai Aug 2004 A1
20040176715 Nelson Sep 2004 A1
20040181156 Kingsford et al. Sep 2004 A1
20040181254 Choi et al. Sep 2004 A1
20040199090 Sanders et al. Oct 2004 A1
20040210167 Webster Oct 2004 A1
20040236258 Burns et al. Nov 2004 A1
20050070828 Hampson et al. Mar 2005 A1
20050143683 Waldridge et al. Jun 2005 A1
20050154336 Kloecker et al. Jul 2005 A1
20050187503 Tordella et al. Aug 2005 A1
20050209545 Farrow et al. Sep 2005 A1
20050242315 Lund Nov 2005 A1
20060010574 Linnane et al. Jan 2006 A1
20060020236 Ben-Nun Jan 2006 A1
20060026736 Nordt et al. Feb 2006 A1
20060089617 Bunnelle Apr 2006 A1
20060102423 Lang et al. May 2006 A1
20060135894 Linnane et al. Jun 2006 A1
20060137072 Visco et al. Jun 2006 A1
20060142719 Vogt et al. Jun 2006 A1
20060161081 Barak et al. Jul 2006 A1
20060189907 Pick et al. Aug 2006 A1
20060211965 Horn et al. Sep 2006 A1
20060287672 McEwen et al. Dec 2006 A1
20060293151 Rast Dec 2006 A1
20070038167 Tabron et al. Feb 2007 A1
20070055188 Avni et al. Mar 2007 A1
20070129658 Hampson et al. Jun 2007 A1
20070130732 Matsumura et al. Jun 2007 A1
20070135835 McEwen et al. Jun 2007 A1
20070135836 McEwen et al. Jun 2007 A1
20070179416 Obrien et al. Aug 2007 A1
20070197947 Scott Aug 2007 A1
20070260162 Meyer et al. Nov 2007 A1
20070264497 Kong Nov 2007 A1
20070276310 Lipshaw et al. Nov 2007 A1
20070276311 Wieringa et al. Nov 2007 A1
20070282233 Meyer et al. Dec 2007 A1
20080000477 Huster et al. Jan 2008 A1
20080004555 Reis et al. Jan 2008 A1
20080004560 Miskie Jan 2008 A1
20080023423 Duffy Jan 2008 A1
20080071204 Linnane et al. Mar 2008 A1
20080072629 Gehring Mar 2008 A1
20080082029 Diana Apr 2008 A1
20080086071 Weatherly Apr 2008 A1
20080087740 Gusenoff et al. Apr 2008 A1
20080103397 Barak May 2008 A1
20080103422 Perry et al. May 2008 A1
20080141428 Kapah et al. Jun 2008 A1
20080143007 Tuma Jun 2008 A1
20080183115 Pierce Jul 2008 A1
20080188786 Hickling Aug 2008 A1
20080208092 Sawa Aug 2008 A1
20080234615 Cook et al. Sep 2008 A1
20080243173 Thorpe Oct 2008 A1
20080245361 Brown Oct 2008 A1
20080249440 Avitable et al. Oct 2008 A1
20080249441 Avitable et al. Oct 2008 A1
20080249443 Avitable et al. Oct 2008 A1
20080249449 Brown et al. Oct 2008 A1
20080249559 Brown et al. Oct 2008 A1
20080250551 Mazzarolo Oct 2008 A1
20080255485 Johnson et al. Oct 2008 A1
20080281351 Croushorn et al. Nov 2008 A1
20080306420 Vess Dec 2008 A1
20080312682 Shams et al. Dec 2008 A1
20090005718 Lightbourne Jan 2009 A1
20090064919 Greenwald Mar 2009 A1
20090082708 Scott et al. Mar 2009 A1
20090099562 Ingimudarson et al. Apr 2009 A1
20090110890 Garza et al. Apr 2009 A1
20090124944 Ravikumar May 2009 A1
20090133446 Burrow et al. May 2009 A1
20090137938 Parivash May 2009 A1
20090163842 Cropper Jun 2009 A1
20090171223 McEwen et al. Jul 2009 A1
20090198160 Coyne Aug 2009 A1
20090198261 Schweikert Aug 2009 A1
20090227917 Nardi Sep 2009 A1
20090227919 Nardi et al. Sep 2009 A1
20090227922 Nardi et al. Sep 2009 A1
20090234265 Reid, Jr. et al. Sep 2009 A1
20090270910 Hargens et al. Oct 2009 A1
20090278707 Biggins et al. Nov 2009 A1
20090281470 Sandusky et al. Nov 2009 A1
20090299249 Wilkes et al. Dec 2009 A1
20090312681 McSpadden et al. Dec 2009 A1
20090320174 Turner Dec 2009 A1
20090326576 Ben-Nun Dec 2009 A1
20100004575 Vess Jan 2010 A1
20100004676 McEwen et al. Jan 2010 A1
20100010408 Linares Jan 2010 A1
20100016771 Arbesman et al. Jan 2010 A1
20100022930 Koby et al. Jan 2010 A1
20100037369 Reichert Feb 2010 A1
20100042026 Kloecker et al. Feb 2010 A1
20100042028 Frank et al. Feb 2010 A1
20100081974 Vess Apr 2010 A1
20100081975 Avitable et al. Apr 2010 A1
20100081977 Vess Apr 2010 A1
20100210982 Balachandran et al. Aug 2010 A1
20100268130 Khan Oct 2010 A1
20120071801 Avitable Mar 2012 A1
20120078146 Deshpande Mar 2012 A1
20130184623 Fraser Jul 2013 A1
20130310719 Davis et al. Nov 2013 A1
20140236058 Lee Aug 2014 A1
Foreign Referenced Citations (31)
Number Date Country
2582678 Apr 2006 CA
1009155 Jan 1987 CN
19846922 Oct 2011 DE
0221636 May 1987 EP
0303029 Feb 1989 EP
0408049 Jan 1991 EP
0861651 Sep 1998 EP
0893115 Jan 1999 EP
1468816 Oct 2004 EP
1980228 Oct 2008 EP
2813770 Mar 2002 FR
2950245 Sep 2009 FR
2061086 May 1981 GB
2178663 Feb 1987 GB
2183483 Jun 1987 GB
2313784 Dec 1997 GB
2373444 Sep 2002 GB
59218154 Dec 1984 JP
60135110 Sep 1985 JP
09262261 Oct 1997 JP
2002065782 Mar 2002 JP
2003310312 Nov 2003 JP
2004081709 Mar 2004 JP
2005066247 Mar 2005 JP
2009000277 Jan 2009 JP
9620685 Jul 1996 WO
2004012644 Feb 2004 WO
2004021950 Mar 2004 WO
2005082315 Sep 2005 WO
2006039242 Apr 2006 WO
2006083865 Aug 2006 WO
Non-Patent Literature Citations (37)
Entry
Mittelman, Jonathan S., MD: “Effectiveness of Leg Compression in Preventing Venous Stasis”, The American Journal of Surgery, Dec. 1982, p. 611-613, vol. 144, No. 6, Elsevier Publ., Bridgewater, NJ, USA.
Tyco Healthcare Kendall, SCD Response Catalog, Mar. 2000, pp. 1-2.
Tyco Healthcare Kendall, SCD Soft Sleeve Catalog, Apr. 2001, pp. 1-2.
The Kendall Company, Vascular Therapy Products Catalog, Jan. 1996, pp. 8-5 thru 8-7.
The Kendall Company, The New SCD Compression Sleeve, Aug. 1993, pp. 1-2.
Tyco Healthcare Kendall, Prevention Gets Personal Mar. 2001, pp. 1, 2, 4.
Kendall SCD, Sequential Compression Sleeves, Patent Information, Jan. 1993, 6 pgs.
Ramsley and Bushnell, “Development of the US Woodland Battle Dress Uniform”, Jan. 1981, p. 8 paragraph 4.
Office action issued Nov. 18, 2010 regarding U.S. Appl. No. 12/242,268, 8 pgs.
Response filed Dec. 13, 2010 to Office Action dated Nov. 18, 2010 regarding U.S. Appl. No. 12/242,268, 5 pgs.
Office action issued Jan. 20, 2011 regarding U.S. Appl. No. 12/242,268, 14 pgs.
Response filed Apr. 19, 2011 to Office Action dated Jan. 20, 2011 regarding U.S. Appl. No. 12/242,268, 13 pgs.
Office action issued May 24, 2011 regarding U.S. Appl. No. 12/242,268, 15 pgs.
Response filed Aug. 24, 2011 to Office Action dated May 24, 2011 regarding U.S. Appl. No. 12/242,268, 8 pgs.
Office Action issued Sep. 13, 2011 from related Japanese Patent Application No. 2008-523432, 4 pgs (Translation).
Office action issued Nov. 8, 2012 in related U.S. Appl. No. 13/362,166, 8 pgs.
Response filed Feb. 8, 2013 to Office Action dated Nov. 8, 2012 regarding U.S. Appl. No. 13/362,166, 14 pgs.
Office action issued Dec. 3, 2012 in related U.S. Appl. No. 13/362,154, 10 pgs.
Response filed Mar. 4, 2013 to Office Action dated Dec. 3, 2012 regarding U.S. Appl. No. 13/362,154—14 pgs.
Office action issued Mar. 15, 2013 regarding U.S. Appl. No. 13/362,166, 13 pgs.
Response filed Jun. 14, 2013 to Office Action dated Mar. 15, 2013 regarding U.S. Appl. No. 13/362,166—13 pgs.
Office action issued Aug. 28, 2013 regarding U.S. Appl. No. 13/362,166,13 pgs.
Response filed Nov. 27, 2013 to Office Action dated Aug. 28, 2013 regarding U.S. Appl. No. 13/362,166—12 pgs.
Office action issued Dec. 18, 2013 regarding U.S. Appl. No. 13/362,166, 14 pgs.
Office action issued Jun. 10, 2011 regarding Chinese Patent Application No. 200680035366.6, 8 pgs.
Office action issued Mar. 29, 2013 regarding U.S. Appl. No. 11/996,995, 8 pgs.
Response filed Jun. 28, 2013 to Office Action dated Mar. 29, 2013 regarding U.S. Appl. No. 11/996,995—7 pgs.
Chinese Office action issued Mar. 31, 2012 regarding Chinese Patent Application Serial No. 200680035366.6, 6 pgs.
Chinese Office action issued Nov. 5, 2012 regarding Chinese Patent Application Serial No. 200680035366.6, 4 pgs.
Japanese Office action issued Apr. 3, 2012 regarding Japanese Patent Application Serial No. 2008-523432, 2 pgs.
Office action issued Nov. 9, 2011 regarding U.S. Appl. No. 12/241,914, 9 pgs.
Response filed Jan. 12, 2012 to Office Action dated Nov. 9, 2011 regarding U.S. Appl. No. 12/241,914, 13 pgs.
Response filed Mar. 7, 2014 to Office action issued Dec. 18, 2013 in related U.S. Appl. No. 13/362,166, 9 pages.
Office action issued Feb. 12, 2015 in related U.S. Appl. No. 13/362,166, 19 pages.
Response filed May 11, 2015 to Office action issued Feb. 12, 2015 in related U.S. Appl. No. 13/362,166, 14 pages.
Office Action dated Sep. 28, 2014 in related Chinese application serial No. 201310159529.3 , 13 pages.
Office action issued Jul. 15, 2015 in related U.S. Appl. No. 13/362,166, 16 pages.
Related Publications (1)
Number Date Country
20140166184 A1 Jun 2014 US
Divisions (1)
Number Date Country
Parent 11996995 US
Child 14021566 US